<DOC>
	<DOCNO>NCT00460213</DOCNO>
	<brief_summary>The purpose study compare improvement percentage urinary albumin excretion valsartan 80 mg- valsartan 160 mg-based therapy patient morning hypertension .</brief_summary>
	<brief_title>Valsartan Optimal Therapy Against Elevated Home Blood Pressure Research（VOYAGER）Study</brief_title>
	<detailed_description>The cardiovascular disease stroke myocardial infarction consist 50 % cause death Japanese population . Numerous mega trial show strict anti-hypertensive therapy could reduce cardiovascular morbidity mortality hypertensive patient . It report , however , 50 % hypertensive patient control therapeutic target blood pressure JSH2004 guideline recommend . Recently use Angiotensin II receptor blocker ( ARBs ) increase progressively pharmacological action organ protection well potent reduction blood pressure . However , usual dosage ARB Japan almost half mega trial execute Europe America . Lower dosage compare western country might reason cardiovascular event fully reduce Japan . Valsartan optimal therapy elevate home blood pressure research ( VOYAGER ) study multi-center , open-label , randomize , active-controlled study evaluate follow ; improvement percentage urinary albumin exception , home blood pressure , hospital blood pressure , incidence stroke , cardiovascular disease , microangiopathy valsartan 80 mg- valsartan 160 mg base therapy patient elevate morning home blood pressure .</detailed_description>
	<mesh_term>Valsartan</mesh_term>
	<criteria>Outpatients age 20 year less 80 year , regardless sex . Patients stable seated morning home blood pressure 135 mmHg and/or diastolic blood pressure 85 mmHg within 1 2 week . Patients therapy conventional dosage ARB . Patients difficult measure home blood pressure . Patients secondary hypertension malignant hypertension . Patients seat systolic blood pressure 200 mmHg . Patients seat diastolic blood pressure 120 mmHg . Patients history cerebrovascular disorder myocardial infarction heart failure within 6 month prior enrolment study . Patients atrial fibrillation , atrial flutter , serious arrhythmia . Patients renal dysfunction serum creatinine level 2 mg/dL . Patients serious liver dysfunction . Patient HbA1C 8 percent . Patient positive albuminuria dip read stick test . Patient treat angiotensin convert enzyme inhibitor Pregnant woman Patients history hypersensitivity valsartan . Other patient judge inappropriate study investigator subinvestigator .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>home blood pressure</keyword>
</DOC>